CPAR Uganda Ltd

facebook twitter 
 

Discussion of Research Findings on the Use of GeneXpert Technology in Greater Northern Uganda

The “gold standard has to be the GeneXpert” asserted respondents in CPAR Uganda’s qualitative investigation into pulmonary tuberculosis (TB). GeneXpert machines facilitate diagnosis of TB. As of 2010 GeneXpert is a World Health Organisation recommended technology for detecting TB. The Uganda National TB and Leprosy Control Programme (NTLP), in its current strategic plan, recommend the use of GeneXpert machines, if available, as “the test of first choice for all presumptive TB cases.” CPAR Uganda explored the use of GeneXpert technology in Uganda; however, this discussion only covers its findings for Uganda’s Greater Northern Region. A PDF of the full discussion (4 pages) is available to download free from the CPAR Uganda website. CLICK HERE TO DOWNLOAD.

Read more: Discussion of Research Findings on the Use of GeneXpert Technology in Greater Northern Uganda

Discussion of Research Findings on Prevalence of Tuberculosis in Greater Northern Uganda

The Ministry of Health, estimates Uganda’s national tuberculosis (TB) prevalence rate at 253/100,000; an estimated 87,000 TB cases annually. CPAR Uganda’s qualitative investigation into TB, indeed, explored prevalence of TB in Uganda. However, this discussion only covers its findings for Uganda’s Greater Northern Region, the region. A PDF of the full discussion (3 pages) is available to download free from the CPAR Uganda website. CLICK HERE TO DOWNLOAD.

Read more: Discussion of Research Findings on Prevalence of Tuberculosis in Greater Northern Uganda

‘Tuberculosis Attitude’ in Uganda’s Greater Northern Region

CPAR Uganda Ltd (CPAR) conducted a qualitative investigation in to pulmonary tuberculosis (PTB) in Uganda, from 2016 to 2017, as part of the “Tuberculosis: Working to Empower The Nations Diagnostic Efforts (TWENDE)” research and advocacy project that was funded by the EDCTP  under its second programme, EDCTP2, that was funded by Horizon 2020 European Union funding for research innovation.

Read more: ‘Tuberculosis Attitude’ in Uganda’s Greater Northern Region

‘Tuberculosis Economics’ in Uganda’s Greater Northern Region

 

CPAR Uganda Ltd (CPAR) conducted a qualitative investigation in to pulmonary tuberculosis (PTB) in Uganda, from 2016 to 2017, as part of the “Tuberculosis: Working to Empower The Nations Diagnostic Efforts (TWENDE)” research and advocacy project that was funded by the EDCTP  under its second programme, EDCTP2, that was funded by Horizon 2020 European Union funding for research innovation. 

Read more: ‘Tuberculosis Economics’ in Uganda’s Greater Northern Region

Managing Tuberculosis Diagnostics Uganda’s Greater Northern Region

 

CPAR Uganda Ltd (CPAR) conducted a qualitative investigation in to pulmonary tuberculosis (PTB) in Uganda, from 2016 to 2017, as part of the “Tuberculosis: Working to Empower The Nations Diagnostic Efforts (TWENDE)” research and advocacy project that was funded by the EDCTP  under its second programme, EDCTP2, that was funded by Horizon 2020 European Union funding for research innovation.

This briefing which is based on a second level analysis of the CPAR TWENDE qualitative data set for the greater northern Uganda is the sixth in a series of briefings through which CPAR is sharing its findings.  It contains the findings for only one aspect – management of PTB diagnostics in greater northern Uganda, covering:

Read more: Managing Tuberculosis Diagnostics Uganda’s Greater Northern Region

Capacity to Test for Tuberculosis Uganda’s Greater Northern Region

 

This is the fifth in a series of briefings through which CPAR Uganda Ltd (CPAR) is sharing findings of its qualitative investigation in to tuberculosis (TB) in Uganda. CPAR conducted its investigation from 2016 to 2017 as part of the “Tuberculosis: Working to Empower The Nations Diagnostic Efforts (TWENDE)” research and advocacy project that was funded by the EDCTP  under its second programme, EDCTP2, that was funded by Horizon 2020 European Union funding for research innovation.

 

Read more: Capacity to Test for Tuberculosis Uganda’s Greater Northern Region

Letter to the UN TB Ambassador for Uganda

Bebe Cool, hearty congratulations on your nomination as the CELEBRITY TUBERCULOSIS AMBASSADOR for Uganda’s camping to end tuberculosis (TB). On your nomination and as you headed to the UN General Assembly High-Level Meeting on Ending TB, it is reported that you said this of your role:

"To support the Uganda Stop TB Partnership, Ministry of Health and UNOPS in the campaign to end tuberculosis in Uganda is a big responsibility that me and many Ugandans should embark on to save lives that are lost each passing day because of this killer disease.”

Read more: Letter to the UN TB Ambassador for Uganda

Social Support and Tuberculosis in Uganda’s Greater Northern Region

 

Stigmatisation is somebody trying to live an isolated life, because he thinks he is now not worth in the community. Some people will even go to the extent of committing suicide, because he thinks there is no hope in his living.”

“When someone reaches that point where they feel like they are no longer accepted within the society, this is what I will call social fear in somebody. He needs social psychological support. They need counselling so much.”

Read more: Social Support and Tuberculosis in Uganda’s Greater Northern Region

Tuberculosis Treatment Drugs Uganda’s Greater Northern Region

This is the third in a series of briefings on research findings that CPAR Uganda Ltd (CPAR) is publishing in order to share the findings of its empirical qualitative investigation in to pulmonary tuberculosis (PTB) in Uganda.

CPAR’s briefing number three contains an analysis of its findings on availability and accessibility of PTB treatment drugs in the greater northern region of Uganda, including: Karamoja, Lango, Acholi and West Nile sub-regions. And it is also contains an analysis of CPAR’s findings on the completion rates of PTB treatment in the greater northern Uganda.

CPAR conducted its qualitative investigation into TB in Uganda as part of the TWENDE research and advocacy project that was funded by the EDCTP, under its second programme, EDCTP2, that was funded by Horizon 2020 European Union Funding for Research and innovations.

The full PDF of the brief is available to download here, free of charge.

Read more: Tuberculosis Treatment Drugs Uganda’s Greater Northern Region

The Tuberculosis Suspicion Index Uganda’s Greater Northern Region

 

Aside from one respondent who asserted that “people quickly see that that one has TB or not”, the quote which opens this briefing exemplifies the general feeling among respondents in a CPAR Uganda Ltd (CPAR) qualitative investigation into pulmonary TB (PTB) that there is insufficient understanding of PTB generally among communities in the greater northern region of Uganda; a region which includes: Karamoja, Lango, Acholi and West Nile sub-regions.

Read more: The Tuberculosis Suspicion Index Uganda’s Greater Northern Region